Xponance, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Xponance, Inc.

$12.3 Billion
Q3 2025

A detailed history of Xponance, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 9,499 shares of ARWR stock, worth $391,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,499

Holding current value

$391,928

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$14.71 - $34.49 $139,730 - $327,620	9,499 New	9,499 $327,000
Q4 2024 Feb 10, 2025	BUY	$17.7 - $26.34 $13,168 - $19,596	744 Added 4.47%	17,400 $327,000
Q3 2024 Nov 12, 2024	BUY	$19.36 - $29.54 $3,697 - $5,642	191 Added 1.16%	16,656 $322,000
Q2 2024 Aug 14, 2024	SELL	$21.87 - $28.24 $18,042 - $23,298	-825 Reduced 4.77%	16,465 $427,000
Q1 2024 May 13, 2024	BUY	$27.21 - $39.48 $59,807 - $86,777	2,198 Added 14.56%	17,290 $494,000
Q4 2023 Jan 31, 2024	SELL	$21.2 - $31.03 $784 - $1,148	-37 Reduced 0.24%	15,092 $461,000
Q3 2023 Oct 23, 2023	SELL	$26.2 - $36.08 $5,921 - $8,154	-226 Reduced 1.47%	15,129 $406,000
Q2 2023 Jul 13, 2023	SELL	$25.16 - $41.38 $30,267 - $49,780	-1,203 Reduced 7.27%	15,355 $547,000
Q1 2023 Apr 17, 2023	BUY	$23.68 - $38.51 $6,227 - $10,128	263 Added 1.61%	16,558 $420,000
Q4 2022 Jan 23, 2023	SELL	$28.0 - $40.56 $364 - $527	-13 Reduced 0.08%	16,295 $0
Q3 2022 Oct 24, 2022	BUY	$29.63 - $48.31 $444 - $724	15 Added 0.09%	16,308 $539,000
Q2 2022 Aug 02, 2022	BUY	$27.79 - $50.61 $24,927 - $45,397	897 Added 5.83%	16,293 $574,000
Q1 2022 Apr 20, 2022	BUY	$39.62 - $69.97 $2,654 - $4,687	67 Added 0.44%	15,396 $708,000
Q4 2021 Jan 31, 2022	SELL	$58.09 - $82.51 $15,916 - $22,607	-274 Reduced 1.76%	15,329 $1.02 Million
Q3 2021 Nov 05, 2021	SELL	$58.38 - $84.96 $37,538 - $54,629	-643 Reduced 3.96%	15,603 $974,000
Q2 2021 Aug 12, 2021	BUY	$62.15 - $90.32 $303,478 - $441,032	4,883 Added 42.97%	16,246 $1.35 Million
Q1 2021 May 10, 2021	SELL	$61.35 - $90.47 $136,442 - $201,205	-2,224 Reduced 16.37%	11,363 $753,000
Q4 2020 Feb 11, 2021	BUY	$43.82 - $85.37 $2,541 - $4,951	58 Added 0.43%	13,587 $1.04 Million
Q3 2020 Oct 26, 2020	SELL	$33.21 - $51.27 $8,900 - $13,740	-268 Reduced 1.94%	13,529 $583,000
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $360,377 - $596,996	13,797 New	13,797 $596,000

Others Institutions Holding ARWR

# of Institutions

340

Shares Held

101M

Call Options Held

979K

Put Options Held

496K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.37B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account